SCHEMBL29319846

SCHEMBL29319846

Cc1nc(Cl)nc2c1C1(CC1)C(=O)N2

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29319837 0.77 — —
SCHEMBL30748834 0.77 PGR (0.33) —
SCHEMBL29195972 0.77 PGR (0.33) —
SCHEMBL30749125 0.76 PGR (0.35) —
SCHEMBL31627002 0.70 PIM1 (0.30) —
SCHEMBL30748876 0.67 KCNH2 (0.32) —
SCHEMBL29195979 0.67 KCNH2 (0.32) —
SCHEMBL21492262 0.67 — —
SCHEMBL16446622 0.66 MAPK14 (0.37) —
SCHEMBL29319840 0.64 SRC (0.53) —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20240239808-A1 INHIBITING UBIQUITIN-SPECIFIC PROTEASE 1 (USP1) FORMA THERAPEUTICS, INC. (US) 2024-07-18 — — US disclosed
Send feedback